Hinge Health, Inc.
HNGE
$48.91
-$1.14-2.28%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | 53.27% | 54.85% | 49.71% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 53.27% | 54.85% | 49.71% | ||
| Cost of Revenue | 30.84% | 74.26% | -4.75% | ||
| Gross Profit | 59.32% | 48.09% | 72.99% | ||
| SG&A Expenses | 69.21% | 572.55% | 6.70% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 53.43% | 570.32% | -3.02% | ||
| Operating Income | -57.65% | -3,208.47% | 141.80% | ||
| Income Before Tax | -212.97% | -5,313.08% | 564.95% | ||
| Income Tax Expenses | -81.42% | -190.86% | 531.65% | ||
| Earnings from Continuing Operations | -640.76% | -5,159.36% | 558.41% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -640.76% | -5,159.36% | 558.41% | ||
| EBIT | -57.65% | -3,208.47% | 141.80% | ||
| EBITDA | -70.18% | -3,313.11% | 144.27% | ||
| EPS Basic | -541.51% | -1,271.38% | 472.97% | ||
| Normalized Basic EPS | -119.82% | -1,311.61% | 156.09% | ||
| EPS Diluted | -541.51% | -1,272.04% | 472.48% | ||
| Normalized Diluted EPS | -124.12% | -1,311.61% | 156.09% | ||
| Average Basic Shares Outstanding | 478.86% | 224.74% | 22.91% | ||
| Average Diluted Shares Outstanding | 375.51% | 224.74% | 22.91% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||